within Pharmacolibrary.Drugs.ATC.G;

model G03GB02
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 2.5e-05,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.15,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0004,
    Tlag           = 600,            
    Vdp             = 0.8,
    k12             = 1.0,
    k21             = 1.0
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03GB02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Clomifene (or clomiphene) is a selective estrogen receptor modulator (SERM) primarily used to treat infertility in women by inducing ovulation. It is also sometimes used off-label in men for hypogonadism. Clomifene is an oral medication and remains an approved therapy for certain cases of female infertility.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult women following oral administration.</p><h4>References</h4><ol><li><p>Casper, RF, &amp; Mitwally, MF (2006). Review: aromatase inhibitors for ovulation induction. <i>The Journal of clinical endocrinology and metabolism</i> 91(3) 760–771. DOI:<a href=\"https://doi.org/10.1210/jc.2005-1923\">10.1210/jc.2005-1923</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16384846/\">https://pubmed.ncbi.nlm.nih.gov/16384846</a></p></li><li><p>Kim, MJ, et al., &amp; Choi, CI (2018). Effect of the CYP2D6*10 allele on the pharmacokinetics of clomiphene and its active metabolites. <i>Archives of pharmacal research</i> 41(3) 347–353. DOI:<a href=\"https://doi.org/10.1007/s12272-018-1005-7\">10.1007/s12272-018-1005-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29516347/\">https://pubmed.ncbi.nlm.nih.gov/29516347</a></p></li><li><p>Szutu, M, et al., &amp; Dollman, W (1989). Pharmacokinetics of intravenous clomiphene isomers. <i>British journal of clinical pharmacology</i> 27(5) 639–640. DOI:<a href=\"https://doi.org/10.1111/j.1365-2125.1989.tb03430.x\">10.1111/j.1365-2125.1989.tb03430.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2757886/\">https://pubmed.ncbi.nlm.nih.gov/2757886</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03GB02;
